Modulation of angiogenesis with siRNA inhibitors for novel therapeutics

Trends in Molecular Medicine

Volumn 11, Issue 3, 2005, Pages 104-113

  Lu, Patrick Y ^a   Xie, Frank Y ^a   Woodle, Martin C ^a  

^a Intradigm Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; CELL ADHESION MOLECULE; INFLIXIMAB; MATRIX METALLOPROTEINASE; RECEPTOR; SMALL INTERFERING RNA; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VATALANIB;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CELL CULTURE; DOWN REGULATION; DRUG MECHANISM; EYE DISEASE; GENE FUNCTION; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; RETINA; REVIEW; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 14844320045     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2005.01.005     Document Type: Review

References (69)

1. R. Kerbel, and J. Folkman Clinical translation of angiogenesis inhibitors Nat. Rev. Cancer 2 2002 727 739
2. S.A. Stacker Lymphangiogenesis and cancer metastasis Nat. Rev. Cancer 2 2002 573 583
3. C. Cursiefen VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J. Clin. Invest. 113 2004 1040 1050
4. M.T. McManus, and P.A. Sharp Gene silencing in mammals by small interfering RNAs Nat. Rev. Genet. 3 2002 737 747
5. P.Y. Lu siRNA-mediated antitumorigenesis for drug target validation and therapeutics Curr. Opin. Mol. Ther. 5 2003 225 234
6. J. Hanze RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation Biochem. Biophys. Res. Commun. 312 2003 571 577
7. J. Wu Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B Cancer Res. 64 2004 2238 2244
8. J.Q. Yin siRNA agents inhibit oncogene expression and attenuate human tumor cell growth J. Exp. Ther. Oncol. 3 2003 194 204
9. 165b) mRNA and protein Am. J. Physiol. Renal Physiol. 286 2004 F767 F773
10. Xie, F.Y. et al. (2004) Delivering siRNA to animal disease models for validation of novel drug targets in vivo. PharmaGenomics July/August, 28-31
11. Y. Takei A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics Cancer Res. 64 2004 3365 3370
12. S.J. Reich Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model Mol. Vis. 9 2003 210 216
13. B. Kim Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor-pathway genes; therapeutic strategy for herpetic stromal keratitis Am. J. Pathol. 165 2004 2177 2185
14. K. Holmqvist The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration J. Biol. Chem. 279 2004 22267 22275
15. M. Yamaoka-Tojo QGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation Circ. Res. 95 2004 276 283
16. R.M. Schiffelers Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically-stablilized nanoparticle Nucleic Acids Res. 32 2004 e149
17. G. Bergers Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nat. Cell Biol. 2 2000 734 744
18. Raghu Kalluri Basement membranes: structure, assembly and role in tumor angiogenesis Nat. Rev. Cancer 3 2003 422 433
19. J. Sanceau Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells J. Biol. Chem. 278 2003 36537 36546
20. von Offenberg Sweeney Cyclic strain-induced endothelial MMP-2: role in vascular smooth muscle cell migration Biochem. Biophys. Res. Commun. 320 2004 325 333
21. L.T. Liu Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion Cancer Res. 63 2003 3069 3072
22. P. Wang Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV J. Biol. Chem. 279 2004 20461 20470
23. T. Murai Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration J. Biol. Chem. 279 2004 4541 4550
24. N. Petrovic CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells J. Biol. Chem. 278 2003 49358 49368
25. Y. Cao Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro Mol. Cell. Biol. 23 2003 6725 6738
26. S. Mori PACSIN3 binds ADAM12/meltrin α and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor J. Biol. Chem. 278 2003 46029 46034
27. M.F. Walsh Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell death Cell. Physiol. Biochem. 13 2003 135 146
28. M.S. Lee Smad2 mediates Erk1/2 activation by TGF-β1 in suspended, but not in adherent, gastric carcinoma cells Int. J. Oncol. 24 2004 1229 1234
29. M.S. Duxbury c-Src-dependent cross-talk between CEACAM6 and αvβ3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components Biochem. Biophys. Res. Commun. 317 2004 133 141
30. C. Tan Regulation of tumor angiogenesis by integrin-linked kinase (ILK) Cancer Cell 5 2004 79 90
31. T. Fukuda PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival J. Biol. Chem. 278 2003 51324 51333
32. Q. Ding The pattern of enhancement of Src kinase activity on platelet-derived growth factor stimulation of glioblastoma cells is affected by the integrin engaged J. Biol. Chem. 278 2003 39882 39891
33. X. Zhou Engagement of αvβ3 integrin regulates proliferation and apoptosis of hepatic stellate cells J. Biol. Chem. 279 2004 23996 24006
34. D. Tsuruta, and J.C. Jones The vimentin cytoskeleton regulates focal contact size and adhesion of endothelial cells subjected to shear stress J. Cell Sci. 116 2003 4977 4984
35. E.A. Lipscomb Use of RNA interference to inhibit integrin (α6β4)-mediated invasion and migration of breast carcinoma cells Clin. Exp. Metastasis 20 2003 569 576
36. P. Nagy Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells Exp. Cell Res. 285 2003 39 49
37. G. Yang Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression J. Biol. Chem. 279 2004 4339 4345
38. L. Zhang RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells J. Biol. Chem. 279 2004 2053 2062
39. Y. Chen Down-regulation of CXCR4 by inducible small interfering RNA inhibits breast cancer cell invasion in vitro Cancer Res. 63 2003 4801 4804
40. M.J. Reginato Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis Nat. Cell Biol. 5 2003 733 740
41. A. Gschwind TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells EMBO J. 22 2003 2411 2421
42. X. Shu Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases Mol. Cell. Biol. 22 2002 7758 7768
43. G. Baldanzi Activation of diacylglycerol kinase α is required for VEGF-induced angiogenic signaling in vitro Oncogene 23 2004 4828 4838
44. S. Le Gouill VEGF induces MCL-1 upregulation and protects multiple myeloma cells against apoptosis Blood 104 2004 2886 2892
45. R. Spagnuolo Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis Blood 103 2004 3005 3012
46. A. Calipel Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway J. Biol. Chem. 278 2003 42409 42418
47. V. Thamilselvan, and M.D. Basson Pressure activates colon cancer cell adhesion by inside-out focal adhesion complex and actin cytoskeletal signaling Gastroenterology 126 2004 8 18
48. A.S. Kumar ILKAP regulates ILK signaling and inhibits anchorage-independent growth Oncogene 23 2004 3454 3461
49. W. Meng DIP (mDia interacting protein) is a key molecule regulating Rho and Rac in a Src-dependent manner EMBO J. 23 2004 760 771
50. C.P. Tseng Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells FEBS Lett. 541 2003 21 27
51. S. Sato Involvement of 3-phosphoinositide-dependent protein kinases-1 in the MEK/MAPK signal-transduction pathway J. Biol. Chem. 279 2004 33759 33767
52. J. Xu TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor J. Biol. Chem. 279 2004 10459 10468
53. Lu, P.Y. and Woodle, M. (2005) Delivering siRNA in vivo For functional genomics can novel therapeutics. In RNA Interference Technology, pp. 303-317, Cambridge University Press
54. S. Filleur siRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth Cancer Res. 63 2003 3919 3922
55. S.W. Han VEGF gene polymorphisms and susceptibility to rheumatoid arthritis Rheumatology (Oxford) 43 2004 1173 1177
56. B. Gudbjornsson Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis Scand. J. Clin. Lab. Invest. 64 2004 9 15
57. K. Grosios Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis Inflamm. Res. 53 2004 133 142
58. P.A. Klimiuk Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab Arch. Immunol. Ther. Exp. (Warsz.) 52 2004 36 42
59. H.G. Zhang Novel tumor necrosis factor α-regulated genes in rheumatoid arthritis Arthritis Rheum. 50 2004 420 431
60. T. Miyashita Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells Biochem. Biophys. Res. Commun. 312 2003 397 404
61. T.A. Dowds Cryopyrin-induced interleukin 1β secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC J. Biol. Chem. 279 2004 21924 21928
62. R.M. Schiffelers Pharmaceutical prospects for RNA interference Pharm. Res. 21 2004 1 7
63. A. Jackson Expression profiling reveals off-target gene regulation by RNAi Nat. Biotechnol. 21 2003 635 637
64. C.A. Sledz Activation of the interferon system by short-interfering RNAs Nat. Cell Biol. 5 2003 834 839
65. K. Kariko Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3 J. Immunol. 172 2004 6545 6549
66. J.D. Heidel Lack of interferon response in animals to naked siRNAs Nat. Biotechnol. 22 2004 1579 1582
67. G. Beale Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system J. Drug Target. 11 2003 449 456
68. Y. Aoki RNA interference may be more potent than antisense RNA in human cancer cell lines Clin. Exp. Pharmacol. Physiol. 30 2003 96 102
69. B.J. Zheng Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus Antivir. Ther. 9 2004 365 374